ATLANTA, GA - (NewMediaWire) - June 27, 2024 - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, announced ...
10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen, vaccine candidate (GEO-CM04S1) to an approved vaccine against COVID-19 under BARDA's Clinical Studies ...
Walmart this spring will roll out clinical research sites in a limited number of stores and former shuttered clinic sites in an effort to increase patient access.
Building the Future of Clinical Research: How CDMOs Can Accelerate the Shift to Decentralized Trials
This article explores how decentralized clinical trials transform biotech drug development, enhancing patient access and ...
Walgreens has received a project award valued up to $25 million through the Rapid Response Partnership Vehicle to conduct a Phase IV observational clinical study focused on assessing Correlates of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results